3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one

Introduction

CAS No. :	67074-78-6	MDL No. :	MFCD08062757
Formula :	C7H7N3O	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	HIGOCZJARKJCGG-UHFFFAOYSA-N
M.W :	149.15	Pubchem ID :	13578751
Synonyms :

Physicochemical Properties

Num. heavy atoms :	11
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.14
Num. rotatable bonds :	0
Num. H-bond acceptors :	2.0
Num. H-bond donors :	2.0
Molar Refractivity :	46.8
TPSA :	54.02 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.1 cm/s

Lipophilicity

Log Po/w (iLOGP) :	0.92
Log Po/w (XLOGP3) :	0.15
Log Po/w (WLOGP) :	-0.7
Log Po/w (MLOGP) :	-0.26
Log Po/w (SILICOS-IT) :	0.74
Consensus Log Po/w :	0.17

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-1.26
Solubility :	8.14 mg/ml ; 0.0546 mol/l
Class :	Very soluble
Log S (Ali) :	-0.84
Solubility :	21.5 mg/ml ; 0.144 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-2.55
Solubility :	0.422 mg/ml ; 0.00283 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	2.15

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine